Evidence map›Paper›PMID 31893204›Full record

ArticleEuropean journal of case reports in internal medicine2019

Moyamoya Syndrome after Radiation Therapy: a Clinical Report.

Paulo Almeida, Ana Luísa Rocha, Gonçalo Alves, Tiago Parreira, Maria Luís Silva, António Cerejo, Pedro Abreu, Ana Monteiro

Open access · goldAbstract readCase Reports
In one paragraph

Article in European journal of case reports in internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Paulo AlmeidaDepartment of Internal Medicine, Centro Hospitalar Baixo Vouga, Aveiro, Portugal.
Ana Luísa RochaDepartment of Neurology, Centro Hospitalar Universitário São João, Porto, Portugal.
Gonçalo AlvesDepartment of Neuroradiology, Centro Hospitalar Universitário São João, Porto, Portugal.
Tiago ParreiraDepartment of Neuroradiology, Centro Hospitalar Universitário São João, Porto, Portugal.
Maria Luís SilvaDepartment of Neuroradiology, Centro Hospitalar Universitário São João, Porto, Portugal.
António CerejoClinical Neurosciences and Mental Health Department, Faculty of Medicine of the University of Porto, Portugal.
Pedro AbreuDepartment of Neurology, Centro Hospitalar Universitário São João, Porto, Portugal.
Ana MonteiroClinical Neurosciences and Mental Health Department, Faculty of Medicine of the University of Porto, Portugal.
Hospital de São João · PTCentro Hospitalar do Baixo Vouga · PTUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Moyamoya syndrome (MMS) is a rare, chronic and progressive vasculopathy with a characteristic angiographic pattern and well-recognized predisposing conditions, such as cranial therapeutic radiation. We report the case of a 36-year-old Caucasian female with a history of craniopharyngioma treated with whole-brain radiotherapy 20 years previously. She was admitted to the emergency department with disorientation and imperceptible speech lasting for 1 hour. Upon examination, she had slight motor aphasia, without sensory or motor deficits. However, the neurological deficits worsened on standing position. The computed tomography (CT) angiogram and transcranial Doppler ultrasonography revealed occlusion of the distal portion of the left internal carotid artery (ICA). Mechanical thrombectomy was attempted without success. Head CT was repeated, revealing left periventricular acute ischaemic stroke. The cerebral angiography showed total occlusion of the left ICA with an exuberant network of transdural collateral vessels, confirming MMS. The patient completed a functional rehabilitation program with progressive improvement of deficits and maintained a multidisciplinary follow-up. MMS is a serious late complication from cranial radiation therapy and a well-described risk factor for ischaemic stroke in younger patients. Therefore, early detection and prompt treatment are mandatory, as the consequences can be disastrous, such as cognitive and neurologic decline due to repeated strokes. LEARNING POINTS: Moyamoya syndrome should be considered in younger patients presenting with acute neurologic deficits, particularly those treated with cranial radiotherapy.The treatment of acute stroke in patients with moyamoya syndrome should include intravenous hydration and avoidance of hypotension.The benefit of antiplatelet agents is limited and equivocal for patients with moyamoya syndrome and oral anticoagulants are not recommended for long-term treatment.

Indexed as

craniopharyngiomamoyamoya syndromeRadiotherapy

Identifiers

PMID31893204
PMCPMC6936925
OpenAlexW2990548250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.